Association between Hypertension and Immunosuppression in SARS-CoV-2 Infection
Full Text (PDF)
Diego Chambergo-Michilot 1 * , Isidro Percy Chambergo Campos 2
More Detail
1 Universidad Científica del Sur, Lima, PERU2 Universidad Tecnológica del Perú - Carrera de Contabilidad, Lima, PERU* Corresponding Author

Abstract

Coronavirus disease 2019 (COVID-19) has caused more than 32 million cases and almost a million deaths. Recent reviews have evidenced the role of hypertension in prognosis, nevertheless, its association with immunosuppression in COVID-19 context has not been studied. It was performed a cross-sectional analysis of a large Mexican population with the infection (n= 681 890). Prevalence of immunosuppression and hypertension was 1.10% and 19.50%, respectively. The adjusted model evidenced that hypertension was significantly associated with immunosuppression (odds ratio=1.18, 95% CI=1.11-1.25). Further research in pathways that justify the association between hypertension and immunosuppression in COVID-19 patients is recommended.

Keywords

License

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article Type: Letter to Editor

ELECTRON J GEN MED, Volume 18, Issue 4, August 2021, Article No: em297

https://doi.org/10.29333/ejgm/10867

Publication date: 01 May 2021

Article Views: 1826

Article Downloads: 1926

Open Access References How to cite this article